FDA approves Corcept’s hormonal disorder drug
(Reuters) – U.S. regulators approved Corcept Therapeutics's drug to treat a rare hormonal disorder called Cushing's syndrome. The U.S. Food and Drug Administration approved the drug, to be sold under the name Korlym, for a condition in whi…
View full post on Yahoo! Health News
approves, Corcept's, Disorder, drug, hormonal
